25 XP   0   0   10

2cureX AB
Buy, Hold or Sell?

Let's analyse 2curex together

PenkeI guess you are interested in 2cureX AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of 2cureX AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about 2cureX AB

I send you an email if I find something interesting about 2cureX AB.

Quick analysis of 2curex (30 sec.)










What can you expect buying and holding a share of 2curex? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr0.78
Expected worth in 1 year
kr-0.89
How sure are you?
26.9%

+ What do you gain per year?

Total Gains per Share
kr-1.67
Return On Investment
-470.9%

For what price can you sell your share?

Current Price per Share
kr0.35
Expected price per share
kr0.286 - kr2.07
How sure are you?
50%

1. Valuation of 2curex (5 min.)




Live pricePrice per Share (EOD)

kr0.35

Intrinsic Value Per Share

kr-13.27 - kr-15.33

Total Value Per Share

kr-12.49 - kr-14.55

2. Growth of 2curex (5 min.)




Is 2curex growing?

Current yearPrevious yearGrowGrow %
How rich?$1.2m$5.1m-$2.9m-133.1%

How much money is 2curex making?

Current yearPrevious yearGrowGrow %
Making money-$703.7k-$699.5k-$4.1k-0.6%
Net Profit Margin-18,853.6%-19,334.8%--

How much money comes from the company's main activities?

3. Financial Health of 2curex (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#855 / 1031

Most Revenue
#711 / 1031

Most Profit
#232 / 1031

Most Efficient
#980 / 1031

What can you expect buying and holding a share of 2curex? (5 min.)

Welcome investor! 2curex's management wants to use your money to grow the business. In return you get a share of 2curex.

What can you expect buying and holding a share of 2curex?

First you should know what it really means to hold a share of 2curex. And how you can make/lose money.

Speculation

The Price per Share of 2curex is kr0.354. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of 2curex.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in 2curex, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr0.78. Based on the TTM, the Book Value Change Per Share is kr-0.42 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of 2curex.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.03-7.4%-0.04-11.6%-0.04-11.2%-0.02-6.9%-0.02-5.9%
Usd Book Value Change Per Share-0.02-6.1%-0.04-11.1%0.014.1%0.000.0%0.000.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-6.1%-0.04-11.1%0.014.1%0.000.0%0.000.8%
Usd Price Per Share0.19-0.37-1.02-1.16-1.08-
Price to Earnings Ratio-1.80--2.29--6.44--23.37--27.42-
Price-to-Total Gains Ratio-8.73--9.69--14.58--64.61-875.68-
Price to Book Ratio2.58-2.90-3.43-6.27-7.10-
Price-to-Total Gains Ratio-8.73--9.69--14.58--64.61-875.68-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.033276
Number of shares30051
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.040.00
Usd Total Gains Per Share-0.040.00
Gains per Quarter (30051 shares)-1,177.230.55
Gains per Year (30051 shares)-4,708.932.21
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-4709-471902-8
20-9418-942804-6
30-14127-1413707-4
40-18836-1884609-2
50-23545-235550110
60-28254-282640132
70-32962-329730154
80-37671-376820186
90-42380-423910208
100-47089-4710002210

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.026.00.00.0%0.026.00.00.0%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%4.016.00.020.0%7.019.00.026.9%7.019.00.026.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.026.00.0%0.00.026.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%4.016.00.020.0%7.019.00.026.9%7.019.00.026.9%

Fundamentals of 2curex

About 2cureX AB

2cureX AB (publ) operates as a medtech company in Europe. The company's principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment. It is also conducting various clinical programs for IndiTreat for colorectal, ovarian, and pancreatic cancers. The company was incorporated in 2006 and is based in Copenhagen, Denmark.

Fundamental data was last updated by Penke on 2024-03-25 21:04:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of 2cureX AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit 2curex earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare 2curex to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that kr0.00 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of 2cureX AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-18,853.6%+18,853.6%
TTM-18,853.6%YOY-19,334.8%+481.1%
TTM-18,853.6%5Y-7,637.7%-11,215.9%
5Y-7,637.7%10Y-5,875.1%-1,762.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--159.2%+159.2%
TTM-18,853.6%-202.3%-18,651.3%
YOY-19,334.8%-263.0%-19,071.8%
5Y-7,637.7%-452.4%-7,185.3%
10Y-5,875.1%-589.0%-5,286.1%
1.1.2. Return on Assets

Shows how efficient 2curex is using its assets to generate profit.

  • Above 5% is considered healthy but always compare 2curex to the Biotechnology industry mean.
  • -29.6% Return on Assets means that 2curex generated kr-0.30 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of 2cureX AB:

  • The MRQ is -29.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -30.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-29.6%TTM-30.4%+0.8%
TTM-30.4%YOY-13.2%-17.2%
TTM-30.4%5Y-11.9%-18.5%
5Y-11.9%10Y-10.6%-1.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.6%-12.5%-17.1%
TTM-30.4%-12.2%-18.2%
YOY-13.2%-11.2%-2.0%
5Y-11.9%-13.3%+1.4%
10Y-10.6%-14.6%+4.0%
1.1.3. Return on Equity

Shows how efficient 2curex is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare 2curex to the Biotechnology industry mean.
  • -36.0% Return on Equity means 2curex generated kr-0.36 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of 2cureX AB:

  • The MRQ is -36.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -35.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-36.0%TTM-35.5%-0.5%
TTM-35.5%YOY-14.2%-21.3%
TTM-35.5%5Y-14.0%-21.5%
5Y-14.0%10Y-13.2%-0.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-36.0%-16.0%-20.0%
TTM-35.5%-15.8%-19.7%
YOY-14.2%-13.9%-0.3%
5Y-14.0%-18.2%+4.2%
10Y-13.2%-19.1%+5.9%

1.2. Operating Efficiency of 2cureX AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient 2curex is operating .

  • Measures how much profit 2curex makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare 2curex to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of 2cureX AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-22,140.5%+22,140.5%
TTM-22,140.5%YOY-25,744.1%+3,603.5%
TTM-22,140.5%5Y-9,576.9%-12,563.6%
5Y-9,576.9%10Y-7,366.9%-2,210.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.5%+299.5%
TTM-22,140.5%-208.5%-21,932.0%
YOY-25,744.1%-280.2%-25,463.9%
5Y-9,576.9%-459.9%-9,117.0%
10Y-7,366.9%-596.9%-6,770.0%
1.2.2. Operating Ratio

Measures how efficient 2curex is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are kr0.00 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of 2cureX AB:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM463.899-463.899
TTM463.899YOY380.117+83.781
TTM463.8995Y168.803+295.095
5Y168.80310Y129.849+38.955
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.817-2.817
TTM463.8993.181+460.718
YOY380.1173.609+376.508
5Y168.8035.554+163.249
10Y129.8497.396+122.453

1.3. Liquidity of 2cureX AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if 2curex is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.42 means the company has kr5.42 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of 2cureX AB:

  • The MRQ is 5.425. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.985. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.425TTM8.985-3.560
TTM8.985YOY17.658-8.673
TTM8.9855Y11.283-2.298
5Y11.28310Y9.559+1.724
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4253.987+1.438
TTM8.9854.440+4.545
YOY17.6585.569+12.089
5Y11.2836.158+5.125
10Y9.5596.492+3.067
1.3.2. Quick Ratio

Measures if 2curex is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare 2curex to the Biotechnology industry mean.
  • A Quick Ratio of 5.42 means the company can pay off kr5.42 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of 2cureX AB:

  • The MRQ is 5.425. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.985. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.425TTM8.985-3.560
TTM8.985YOY17.627-8.642
TTM8.9855Y11.227-2.242
5Y11.22710Y9.377+1.850
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4253.653+1.772
TTM8.9854.158+4.827
YOY17.6275.515+12.112
5Y11.2276.012+5.215
10Y9.3776.206+3.171

1.4. Solvency of 2cureX AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of 2curex assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare 2curex to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.18 means that 2curex assets are financed with 17.7% credit (debt) and the remaining percentage (100% - 17.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of 2cureX AB:

  • The MRQ is 0.177. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.127. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.177TTM0.127+0.050
TTM0.127YOY0.063+0.064
TTM0.1275Y0.140-0.013
5Y0.14010Y0.191-0.052
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1770.336-0.159
TTM0.1270.330-0.203
YOY0.0630.267-0.204
5Y0.1400.367-0.227
10Y0.1910.378-0.187
1.4.2. Debt to Equity Ratio

Measures if 2curex is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare 2curex to the Biotechnology industry mean.
  • A Debt to Equity ratio of 21.4% means that company has kr0.21 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of 2cureX AB:

  • The MRQ is 0.214. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.149. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.214TTM0.149+0.066
TTM0.149YOY0.067+0.081
TTM0.1495Y0.183-0.035
5Y0.18310Y0.296-0.113
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2140.376-0.162
TTM0.1490.398-0.249
YOY0.0670.334-0.267
5Y0.1830.431-0.248
10Y0.2960.476-0.180

2. Market Valuation of 2cureX AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings 2curex generates.

  • Above 15 is considered overpriced but always compare 2curex to the Biotechnology industry mean.
  • A PE ratio of -1.80 means the investor is paying kr-1.80 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of 2cureX AB:

  • The EOD is -0.316. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.796. Based on the earnings, the company is expensive. -2
  • The TTM is -2.288. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.316MRQ-1.796+1.480
MRQ-1.796TTM-2.288+0.492
TTM-2.288YOY-6.442+4.154
TTM-2.2885Y-23.368+21.080
5Y-23.36810Y-27.418+4.050
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.316-2.697+2.381
MRQ-1.796-2.422+0.626
TTM-2.288-2.709+0.421
YOY-6.442-4.116-2.326
5Y-23.368-6.257-17.111
10Y-27.418-6.478-20.940
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of 2cureX AB:

  • The EOD is -0.282. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.600. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.057. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.282MRQ-1.600+1.318
MRQ-1.600TTM-2.057+0.457
TTM-2.057YOY-7.188+5.132
TTM-2.0575Y-18.951+16.895
5Y-18.95110Y-16.460-2.492
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.282-3.344+3.062
MRQ-1.600-2.939+1.339
TTM-2.057-3.486+1.429
YOY-7.188-5.592-1.596
5Y-18.951-8.464-10.487
10Y-16.460-8.872-7.588
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of 2curex is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.58 means the investor is paying kr2.58 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of 2cureX AB:

  • The EOD is 0.455. Based on the equity, the company is cheap. +2
  • The MRQ is 2.585. Based on the equity, the company is underpriced. +1
  • The TTM is 2.904. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.455MRQ2.585-2.129
MRQ2.585TTM2.904-0.319
TTM2.904YOY3.430-0.526
TTM2.9045Y6.272-3.369
5Y6.27210Y7.104-0.831
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.4552.198-1.743
MRQ2.5852.042+0.543
TTM2.9042.121+0.783
YOY3.4302.907+0.523
5Y6.2723.682+2.590
10Y7.1044.114+2.990
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of 2cureX AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.230-0.417+81%0.153-250%0.000-117599%0.030-870%
Book Value Per Share--0.7781.342-42%3.127-75%2.380-67%2.019-61%
Current Ratio--5.4258.985-40%17.658-69%11.283-52%9.559-43%
Debt To Asset Ratio--0.1770.127+39%0.063+182%0.140+26%0.191-8%
Debt To Equity Ratio--0.2140.149+44%0.067+219%0.183+17%0.296-28%
Dividend Per Share----0%-0%-0%-0%
Eps---0.280-0.438+56%-0.423+51%-0.259-7%-0.221-21%
Free Cash Flow Per Share---0.314-0.461+47%-0.406+29%-0.282-10%-0.228-27%
Free Cash Flow To Equity Per Share---0.314-0.461+47%-0.406+29%0.337-193%0.285-210%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---15.328--------
Intrinsic Value_10Y_min---13.271--------
Intrinsic Value_1Y_max---1.512--------
Intrinsic Value_1Y_min---1.485--------
Intrinsic Value_3Y_max---4.562--------
Intrinsic Value_3Y_min---4.355--------
Intrinsic Value_5Y_max---7.633--------
Intrinsic Value_5Y_min---7.083--------
Market Cap6231426.600-468%35381861.16069487510.910-49%190155410.370-81%237412490.458-85%216204826.328-84%
Net Profit Margin----188.5360%-193.3480%-76.3770%-58.7510%
Operating Margin----221.4050%-257.4410%-95.7690%-73.6690%
Operating Ratio---463.899-100%380.117-100%168.803-100%129.849-100%
Pb Ratio0.455-468%2.5852.904-11%3.430-25%6.272-59%7.104-64%
Pe Ratio-0.316+82%-1.796-2.288+27%-6.442+259%-23.368+1201%-27.418+1427%
Price Per Share0.354-468%2.0103.948-49%10.803-81%12.389-84%11.438-82%
Price To Free Cash Flow Ratio-0.282+82%-1.600-2.057+29%-7.188+349%-18.951+1084%-16.460+929%
Price To Total Gains Ratio-1.537+82%-8.730-9.686+11%-14.577+67%-64.610+640%875.683-101%
Quick Ratio--5.4258.985-40%17.627-69%11.227-52%9.377-42%
Return On Assets---0.296-0.304+3%-0.132-55%-0.119-60%-0.106-64%
Return On Equity---0.360-0.355-1%-0.142-60%-0.140-61%-0.132-63%
Total Gains Per Share---0.230-0.417+81%0.153-250%0.000-117599%0.030-870%
Usd Book Value--1286860.0002220115.500-42%5174230.000-75%4136333.700-69%3493374.204-63%
Usd Book Value Change Per Share---0.022-0.039+81%0.014-250%0.000-117599%0.003-870%
Usd Book Value Per Share--0.0730.126-42%0.294-75%0.224-67%0.190-61%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.026-0.041+56%-0.040+51%-0.024-7%-0.021-21%
Usd Free Cash Flow---519632.000-762504.500+47%-671136.500+29%-468876.700-10%-379380.997-27%
Usd Free Cash Flow Per Share---0.030-0.043+47%-0.038+29%-0.027-10%-0.021-27%
Usd Free Cash Flow To Equity Per Share---0.030-0.043+47%-0.038+29%0.032-193%0.027-210%
Usd Market Cap585754.100-468%3325894.9496531826.026-49%17874608.575-81%22316774.103-85%20323253.675-84%
Usd Price Per Share0.033-468%0.1890.371-49%1.015-81%1.165-84%1.075-82%
Usd Profit---462950.000-703731.000+52%-699595.000+51%-441358.200-5%-375063.190-19%
Usd Revenue---3924.500-100%2115.000-100%1207.900-100%929.154-100%
Usd Total Gains Per Share---0.022-0.039+81%0.014-250%0.000-117599%0.003-870%
 EOD+3 -5MRQTTM+17 -14YOY+12 -195Y+4 -2710Y+5 -26

3.2. Fundamental Score

Let's check the fundamental score of 2cureX AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.316
Price to Book Ratio (EOD)Between0-10.455
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than15.425
Current Ratio (MRQ)Greater than15.425
Debt to Asset Ratio (MRQ)Less than10.177
Debt to Equity Ratio (MRQ)Less than10.214
Return on Equity (MRQ)Greater than0.15-0.360
Return on Assets (MRQ)Greater than0.05-0.296
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of 2cureX AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5018.289
Ma 20Greater thanMa 501.010
Ma 50Greater thanMa 1001.521
Ma 100Greater thanMa 2001.828
OpenGreater thanClose0.332
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets16,625
Total Liabilities2,935
Total Stockholder Equity13,690
 As reported
Total Liabilities 2,935
Total Stockholder Equity+ 13,690
Total Assets = 16,625

Assets

Total Assets16,625
Total Current Assets15,922
Long-term Assets703
Total Current Assets
Cash And Cash Equivalents 13,403
Net Receivables 2,519
Total Current Assets  (as reported)15,922
Total Current Assets  (calculated)15,922
+/-0
Long-term Assets
Property Plant Equipment 703
Long-term Assets Other 0
Long-term Assets  (as reported)703
Long-term Assets  (calculated)703
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,935
Long-term Liabilities0
Total Stockholder Equity13,690
Total Current Liabilities
Other Current Liabilities 2,935
Total Current Liabilities  (as reported)2,935
Total Current Liabilities  (calculated)2,935
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock1,760
Other Stockholders Equity 11,930
Total Stockholder Equity (as reported)13,690
Total Stockholder Equity (calculated)13,690
+/-0
Other
Cash and Short Term Investments 13,403
Common Stock Shares Outstanding 17,603
Liabilities and Stockholders Equity 16,625
Net Debt -13,403
Net Working Capital 12,987



Balance Sheet

All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
10,842
0
0
8,189
22,846
32,861
30,663
26,450
24,026
21,362
38,849
42,692
37,841
33,515
34,438
67,936
63,044
60,918
87,278
81,824
79,160
69,633
62,561
54,273
47,657
38,580
29,765
21,483
16,625
16,62521,48329,76538,58047,65754,27362,56169,63379,16081,82487,27860,91863,04467,93634,43833,51537,84142,69238,84921,36224,02626,45030,66332,86122,8468,1890010,842
   > Total Current Assets 
9,745
0
0
7,310
22,253
32,266
29,594
25,519
22,642
20,059
37,624
41,555
36,826
32,458
33,457
66,809
62,048
59,971
86,431
81,056
78,469
69,007
61,718
53,451
46,664
37,639
28,888
20,695
15,922
15,92220,69528,88837,63946,66453,45161,71869,00778,46981,05686,43159,97162,04866,80933,45732,45836,82641,55537,62420,05922,64225,51929,59432,26622,2537,310009,745
       Cash And Cash Equivalents 
7,355
0
0
4,818
19,985
30,675
27,838
23,848
20,063
17,167
34,105
38,655
33,720
30,018
30,070
63,977
58,577
53,991
78,913
72,498
72,942
63,348
55,583
47,820
44,894
34,829
26,293
18,104
13,403
13,40318,10426,29334,82944,89447,82055,58363,34872,94272,49878,91353,99158,57763,97730,07030,01833,72038,65534,10517,16720,06323,84827,83830,67519,9854,818007,355
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
2,900
2,819
2,440
3,387
2,832
3,266
5,980
7,518
8,558
4,980
5,659
6,135
5,631
1,192
2,810
2,595
2,591
2,519
2,5192,5912,5952,8101,1925,6316,1355,6594,9808,5587,5185,9803,2662,8323,3872,4402,8192,90000000000000
       Other Current Assets 
2,390
0
0
2,492
2,268
1,591
1,756
1,671
2,579
2,892
3,519
2,900
3,106
2,440
3,387
2,832
3,471
5,980
7,518
8,558
5,527
5,659
6,135
5,631
578
0
0
0
0
00005785,6316,1355,6595,5278,5587,5185,9803,4712,8323,3872,4403,1062,9003,5192,8922,5791,6711,7561,5912,2682,492002,390
   > Long-term Assets 
1,097
0
0
879
593
595
1,069
931
1,384
1,303
1,225
1,137
1,015
1,057
981
1,127
996
947
847
768
691
626
843
822
993
941
877
788
703
7037888779419938228436266917688479479961,1279811,0571,0151,1371,2251,3031,3849311,069595593879001,097
       Property Plant Equipment 
856
0
0
639
593
564
1,004
931
1,384
1,303
1,225
1,137
1,015
1,057
981
1,127
996
947
847
768
691
626
843
822
993
941
877
788
703
7037888779419938228436266917688479479961,1279811,0571,0151,1371,2251,3031,3849311,00456459363900856
       Long-term Assets Other 
241
0
0
240
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-993
-941
-877
0
0
00-877-941-9930000000000000000000024000241
> Total Liabilities 
2,927
0
0
1,162
2,609
15,487
16,351
12,839
10,405
9,143
7,204
12,385
9,765
6,383
10,034
6,794
4,180
3,779
5,529
3,427
4,816
2,887
2,831
3,603
4,623
2,902
2,403
3,740
2,935
2,9353,7402,4032,9024,6233,6032,8312,8874,8163,4275,5293,7794,1806,79410,0346,3839,76512,3857,2049,14310,40512,83916,35115,4872,6091,162002,927
   > Total Current Liabilities 
2,927
0
0
1,162
2,609
15,487
16,351
12,839
10,405
9,143
7,205
12,385
9,765
6,383
10,034
6,794
4,180
3,779
5,529
3,427
4,816
2,887
2,831
3,603
4,623
2,904
2,403
3,740
2,935
2,9353,7402,4032,9044,6233,6032,8312,8874,8163,4275,5293,7794,1806,79410,0346,3839,76512,3857,2059,14310,40512,83916,35115,4872,6091,162002,927
       Accounts payable 
0
0
0
0
1,329
0
0
0
523
0
0
0
1,598
0
0
0
967
0
0
0
2,476
0
0
0
1,629
0
0
0
0
00001,6290002,4760009670001,5980005230001,3290000
       Other Current Liabilities 
2,927
0
0
1,162
1,280
15,487
16,351
12,839
9,882
9,143
7,205
12,385
8,167
6,383
10,034
6,794
3,213
3,779
5,529
3,427
2,340
2,887
2,831
3,603
2,994
2,904
2,403
3,740
2,935
2,9353,7402,4032,9042,9943,6032,8312,8872,3403,4275,5293,7793,2136,79410,0346,3838,16712,3857,2059,1439,88212,83916,35115,4871,2801,162002,927
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
-1
0
0
0
0
0
0
0
0
0
2,476
0
0
0
1,629
-2
0
0
0
000-21,6290002,476000000000-10000000000
> Total Stockholder Equity
7,915
0
0
7,026
20,237
17,374
14,312
13,611
13,621
12,219
31,645
30,307
28,076
27,132
24,404
61,142
58,864
57,139
81,749
78,397
74,344
66,746
59,730
50,670
43,034
35,678
27,362
17,743
13,690
13,69017,74327,36235,67843,03450,67059,73066,74674,34478,39781,74957,13958,86461,14224,40427,13228,07630,30731,64512,21913,62113,61114,31217,37420,2377,026007,915
   Common Stock
277
0
0
276
1,035
1,035
1,035
1,035
1,035
1,035
1,242
1,242
1,242
1,242
1,242
1,485
1,486
1,486
1,729
1,748
1,748
1,760
1,760
1,760
1,760
1,760
1,760
1,760
1,760
1,7601,7601,7601,7601,7601,7601,7601,7601,7481,7481,7291,4861,4861,4851,2421,2421,2421,2421,2421,0351,0351,0351,0351,0351,03527600277
   Retained Earnings 
7,638
0
0
6,750
-3,136
-2,944
-6,049
-6,759
-7,264
-1,537
-4,400
-5,795
-7,933
-1,149
-4,236
-5,046
-7,320
-1,835
-7,300
-12,727
-18,937
-7,897
-14,300
-22,653
-29,770
-7,575
-15,730
-25,894
0
0-25,894-15,730-7,575-29,770-22,653-14,300-7,897-18,937-12,727-7,300-1,835-7,320-5,046-4,236-1,149-7,933-5,795-4,400-1,537-7,264-6,759-6,049-2,944-3,1366,750007,638
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
38,023
38,023
38,023
75,301
75,388
75,388
105,046
106,608
107,663
107,664
107,664
107,664
107,664
107,664
111,864
0
0
00111,864107,664107,664107,664107,664107,664107,663106,608105,04675,38875,38875,30138,02338,02338,023000000000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
22,338
19,283
19,326
19,335
19,850
12,721
34,803
34,860
34,767
27,039
27,398
64,703
64,698
57,488
87,320
89,376
91,533
72,883
72,270
71,563
71,044
41,493
41,332
41,877
11,930
11,93041,87741,33241,49371,04471,56372,27072,88391,53389,37687,32057,48864,69864,70327,39827,03934,76734,86034,80312,72119,85019,33519,32619,28322,3380000



Balance Sheet

All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue155
Cost of Revenue-37,642
Gross Profit-37,487-37,487
 
Operating Income (+$)
Gross Profit-37,487
Operating Expense-33,706
Operating Income-37,487-71,193
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense33,7060
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-1,903
Net Interest Income-1,903
 
Pretax Income (+$)
Operating Income-37,487
Net Interest Income-1,903
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-35,448-39,526
EBIT - interestExpense = -37,487
-35,448
-30,819
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-37,487-35,448
Earnings Before Interest and Taxes (EBITDA)-37,175
 
After tax Income (+$)
Income Before Tax-35,448
Tax Provision-2
Net Income From Continuing Ops-33,011-35,450
Net Income-30,819
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses37,642
Total Other Income/Expenses Net2,0391,903
 

Technical Analysis of 2curex
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of 2curex. The general trend of 2curex is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine 2curex's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of 2cureX AB.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.285 < 1.95 < 2.07.

The bearish price targets are: 0.286.

Tweet this
2cureX AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of 2cureX AB. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

2cureX AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of 2cureX AB. The current macd is -0.35394231.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the 2curex price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for 2curex. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the 2curex price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
2cureX AB Daily Moving Average Convergence/Divergence (MACD) Chart2cureX AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of 2cureX AB. The current adx is 55.37.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell 2curex shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
2cureX AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of 2cureX AB. The current sar is 1.15308734.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
2cureX AB Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of 2cureX AB. The current rsi is 18.29. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
2cureX AB Daily Relative Strength Index (RSI) Chart2cureX AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of 2cureX AB. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the 2curex price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
2cureX AB Daily Stochastic Oscillator Chart2cureX AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of 2cureX AB. The current cci is -89.46192637.

2cureX AB Daily Commodity Channel Index (CCI) Chart2cureX AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of 2cureX AB. The current cmo is -75.10387477.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
2cureX AB Daily Chande Momentum Oscillator (CMO) Chart2cureX AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of 2cureX AB. The current willr is -93.78427788.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
2cureX AB Daily Williams %R Chart2cureX AB Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of 2cureX AB.

2cureX AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of 2cureX AB. The current atr is 0.20516421.

2cureX AB Daily Average True Range (ATR) Chart2cureX AB Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of 2cureX AB. The current obv is -5,325,385.

2cureX AB Daily On-Balance Volume (OBV) Chart2cureX AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of 2cureX AB. The current mfi is 19.78.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
2cureX AB Daily Money Flow Index (MFI) Chart2cureX AB Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for 2cureX AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-09STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

2cureX AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of 2cureX AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5018.289
Ma 20Greater thanMa 501.010
Ma 50Greater thanMa 1001.521
Ma 100Greater thanMa 2001.828
OpenGreater thanClose0.332
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of 2curex with someone you think should read this too:
  • Are you bullish or bearish on 2curex? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about 2curex? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about 2cureX AB

I send you an email if I find something interesting about 2cureX AB.


Comments

How you think about this?

Leave a comment

Stay informed about 2cureX AB.

Receive notifications about 2cureX AB in your mailbox!